Video

Aerie COO: Expanding innovation of glaucoma therapeutics

Author(s):

OT Staff Reports
Conferences|GLAUCOMA 360

Tom Mitro, president, COO of Aerie Pharmaceuticals, discusses the key highlights from an industry panel discussion titled "Innovate without borders," held during the Glaucoma 360 New Horizons Forum, including the company's role in expanding into the global glaucoma therapeutics market.

See more Glaucoma 360 coverage

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
AAO 2024: Weijie Violet Lin, MD, discusses risk factors for epithelium-off cross-linking
Related Content
SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension
November 19th 2024

SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Long-term blood pressure variability and visual field progression in glaucoma
November 18th 2024

Long-term blood pressure variability and visual field progression in glaucoma

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

AI-related innovations for laser cataract technology mark a milestone in history of device
October 30th 2024

AI-related innovations for laser cataract technology mark a milestone in history of device

A history of the femtosecond laser in the United States and Europe
October 25th 2024

A history of the femtosecond laser in the United States and Europe

© 2024 MJH Life Sciences

All rights reserved.